|
Changes in HIV Testing After Implementation of Name-Based HIV Case Surveillance in New Mexico
November 8, 2002 New Mexico implemented name-based HIV case surveillance on
Jan. 15, 1998. The current study undertook to assess changes in
HIV testing patterns after HIV case surveillance was implemented.
The timing of the HIV Testing Survey (HITS), developed to gather
data on HIV testing patterns among at-risk persons through
anonymous, cross-sectional surveys, offered a natural experiment
in New Mexico. HITS-I took place in 1996 (pre-surveillance), and
HITS-II took place in 1998, after the state implemented HIV case
surveillance.
Researchers surveyed men who had sex with men, whom they recruited from gay bars; injection drug users, recruited through street outreach; and heterosexual adults, recruited from an STD clinic. Participants were persons age 18 or older who were New Mexico residents for at least 1 year. Researchers used Fisher exact tests or chi-square tests to compare categorical variables to see if they differed significantly between HITS-I and HITS-II. Eighty-four percent of HITS-I participants and 82 percent of HITS-II participants had been tested at least once for HIV. The percentage of participants who had been tested anonymously was higher in HITS-II (56 percent) than in HITS-I (45 percent). Yet concerns about confidentiality were cited as a reason not to be tested by only 23 percent of HITS-1 untested respondents and 4 percent of HITS-II untested participants. Participants most commonly cited the fear of finding out they were HIV-positive or the belief that they were HIV-negative as reasons for not being tested. The proportion of participants being tested did not differ among those who knew the state's surveillance policy and those who did not. Ten percent of HITS-II participants correctly identified the current HIV surveillance policy. Three percent correctly identified the state's surveillance policy in HITS-I. Back to other CDC news for November 8, 2002 American Journal of Public Health 11.02; Vol. 92; No. 11: P. 1757; Amy Lansky, Ph.D., M.P.H.; J. Stan Lehman, M.P.H.; Jill Gatwood, M.S.; Frederick M. Hecht, M.D.; Patricia L. Fleming, Ph.D.
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. |